BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 33025379)

  • 1. Cryptococcal meningitis in non-HIV patients in the State of Amazonas, Northern Brazil.
    Pinheiro SB; Sousa ES; Cortez ACA; da Silva Rocha DF; Menescal LSF; Chagas VS; Gómez ASP; Cruz KS; Santos LO; Alves MJ; Matsuura ABJ; Wanke B; Trilles L; Frickmann H; de Souza JVB
    Braz J Microbiol; 2021 Mar; 52(1):279-288. PubMed ID: 33025379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil.
    Rocha DFS; Cruz KS; Santos CSDS; Menescal LSF; Neto JRDS; Pinheiro SB; Silva LM; Trilles L; Braga de Souza JV
    PLoS One; 2018; 13(6):e0197841. PubMed ID: 29883489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
    Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients.
    Kassi FK; Drakulovski P; Bellet V; Krasteva D; Gatchitch F; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Mallié M; Menan HIE; Bertout S
    Mycoses; 2016 Dec; 59(12):811-817. PubMed ID: 27461533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil).
    Martins LM; Wanke B; Lazéra Mdos S; Trilles L; Barbosa GG; Macedo RC; Cavalcanti Mdo A; Eulálio KD; Castro JA; Silva AS; Nascimento FF; Gouveia VA; Monte SJ
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):725-30. PubMed ID: 22012227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilocus sequence typing of serially collected isolates of Cryptococcus from HIV-infected patients in South Africa.
    Van Wyk M; Govender NP; Mitchell TG; Litvintseva AP;
    J Clin Microbiol; 2014 Jun; 52(6):1921-31. PubMed ID: 24648562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
    Nyazika TK; Hagen F; Meis JF; Robertson VJ
    J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and antifungal susceptibility profiles of clinical
    Bandalizadeh Z; Shokohi T; Badali H; Abastabar M; Babamahmoudi F; Davoodi L; Mardani M; Javanian M; Cheraghmakani H; Sepidgar AA; Badiee P; Khodavaisy S; Afshari SAK; Ahmadikia K; Seyedmousavi S
    J Med Microbiol; 2020 Jan; 69(1):72-81. PubMed ID: 31750814
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
    Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
    J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the DiversiLab system.
    Dou HT; Xu YC; Wang HZ; Li TS
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):753-62. PubMed ID: 25471194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
    Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
    PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and antifungal susceptibilities of Cryptococcus species isolates from HIV and non-HIV patients in Southwest China.
    Wu SY; Kang M; Liu Y; Chen ZX; Xiao YL; He C; Ma Y
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):287-295. PubMed ID: 32895755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
    Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
    Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.